183 related articles for article (PubMed ID: 12083996)
1. Travoprost--a new prostaglandin analogue for the treatment of glaucoma.
Whitson JT
Expert Opin Pharmacother; 2002 Jul; 3(7):965-77. PubMed ID: 12083996
[TBL] [Abstract][Full Text] [Related]
2. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
[TBL] [Abstract][Full Text] [Related]
3. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
4. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
5. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
[TBL] [Abstract][Full Text] [Related]
6. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
Holló G; Kóthy P
Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.
Hellberg MR; McLaughlin MA; Sharif NA; DeSantis L; Dean TR; Kyba EP; Bishop JE; Klimko PG; Zinke PW; Selliah RD; Barnes G; DeFaller J; Kothe A; Landry T; Sullivan EK; Andrew R; Davis AA; Silver L; Bergamini MV; Robertson S; Weiner AL; Sallee VL
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S13-33. PubMed ID: 12204698
[TBL] [Abstract][Full Text] [Related]
8. Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
Fellman RL; Sullivan EK; Ratliff M; Silver LH; Whitson JT; Turner FD; Weiner AL; Davis AA;
Ophthalmology; 2002 May; 109(5):998-1008. PubMed ID: 11986110
[TBL] [Abstract][Full Text] [Related]
9. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
10. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
[TBL] [Abstract][Full Text] [Related]
11. Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension.
Pfeiffer N;
Graefes Arch Clin Exp Ophthalmol; 2011 Jul; 249(7):1065-71. PubMed ID: 21499770
[TBL] [Abstract][Full Text] [Related]
12. Travoprost/timolol.
Hoy SM; Keam SJ; Keating GM
Drugs Aging; 2006; 23(7):587-97; discussion 598-9. PubMed ID: 16930087
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.
Orengo-Nania S; Landry T; Von Tress M; Silver LH; Weiner A; Davis AA;
Am J Ophthalmol; 2001 Dec; 132(6):860-8. PubMed ID: 11730649
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of latanoprost versus travoprost assessed by daily intraocular pressure curve].
Santos HD; Fernandes TA; Souza CA; Cronemberger S; Calixto N
Arq Bras Oftalmol; 2009; 72(1):13-7. PubMed ID: 19347115
[TBL] [Abstract][Full Text] [Related]
15. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
Easthope SE; Perry CM
Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
[TBL] [Abstract][Full Text] [Related]
16. A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.
Denis P; Andrew R; Wells D; Friren B
Eur J Ophthalmol; 2006; 16(3):407-15. PubMed ID: 16761242
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
Chiseliţă D; Antohi I; Medvichi R; Danielescu C
Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674
[TBL] [Abstract][Full Text] [Related]
18. Travoprost.
Waugh J; Jarvis B
Drugs Aging; 2002; 19(6):465-71; discussion 472-3. PubMed ID: 12149052
[TBL] [Abstract][Full Text] [Related]
19. [Bimatoprost therapy in glaucoma].
Călugăru D; Călugăru M
Oftalmologia; 2009; 53(3):34-45. PubMed ID: 19899545
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]